Restoring implant fixation strength in osteoporotic bone with a hydrogel locally delivering zoledronic acid and bone morphogenetic protein 2. A longitudinal in vivo microCT study in rats
Bone · 2024
DOI: 10.1016/j.bone.2023.117011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bone, 2024. Verfasst von Claudia Siverino und 8 weiteren Autor:innen. Beteiligte Einrichtung: AO Research Institute Davos, Davos, Switzerland. Electronic address: claudia.siverino@aofoundation.org. Hauptthemen laut MEDLINE: Osteoporosis, Bone Density Conservation Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: AO Foundation.
Abstract (Originalsprache)
Osteoporosis poses a major public health challenge, and it is characterized by low bone mass, deterioration of the microarchitecture of bone tissue, causing a consequent increase in bone fragility and susceptibility to fractures and complicating bone fixation, particularly screw implantation. In the present study, our aim was to improve implant stability in osteoporotic bone using a thermoresponsive hyaluronan hydrogel (HA-pNIPAM) to locally deliver the bisphosphonate zoledronic acid (ZOL) to prevent bone resorption and bone morphogenetic protein 2 (BMP2) to induce bone formation. Adult female Wistar rats (n = 36) were divided into 2 treatment groups: one group of SHAM-operated animals and another group that received an ovariectomy (OVX) to induce an osteoporotic state. All animals received a polyetheretherketone (PEEK) screw in the proximal tibia. In addition, subgroups of SHAM or OVX animals received either the HA-pNIPAM hydrogel without or with ZOL/BMP2, placed into the defect site prior to screw implantation. Periprosthetic bone and implant fixation were monitored using longitudinal in vivo microCT scanning post-operatively and at 3, 6, 9, 14, 20 and 28 days. Histological assessment was performed post-mortem. Our data showed that pure hydrogel has no impact of implant fixation The ZOL/BMP2-hydrogel significantly increased bone-implant contact and peri-implant bone fraction, primarily through reduced resorption. STATEMENT OF CLINICAL SIGNIFICANCE: Local delivery of ZOL and BMP2 using a biocompatible hydrogel improved implant stability in osteoporotic bone. This approach could constitute a potent alternative to systemic drug administration and may be useful in avoiding implant loosening in clinical settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AO Research Institute Davos, Davos, Switzerland. Electronic address: claudia.siverino@aofoundation.org.
- AO Research Institute Davos, Davos, Switzerland. Electronic address: laura.tirkkonen-rajasalo@sulapac.com.
- AO Research Institute Davos, Davos, Switzerland. Electronic address: linda-freitag@gmx.de.
- AO Research Institute Davos, Davos, Switzerland.
- AO Research Institute Davos, Davos, Switzerland. Electronic address: keith.thompson@ucb.com.
- AO Research Institute Davos, Davos, Switzerland. Electronic address: ursi.styger@aofoundation.org.
Förderung
- AO Foundation
Zitieren
APA
Siverino, C., Tirkkonen-Rajasalo, L., Freitag, L., Günther, C., Thompson, K., Styger, U., Zeiter, S., Eglin, D., & Stadelmann, V. A. (2024). Restoring implant fixation strength in osteoporotic bone with a hydrogel locally delivering zoledronic acid and bone morphogenetic protein 2. A longitudinal in vivo microCT study in rats. Bone. https://doi.org/10.1016/j.bone.2023.117011
Vancouver
Siverino C, Tirkkonen-Rajasalo L, Freitag L, Günther C, Thompson K, Styger U, et al. Restoring implant fixation strength in osteoporotic bone with a hydrogel locally delivering zoledronic acid and bone morphogenetic protein 2. A longitudinal in vivo microCT study in rats. Bone. 2024. doi:10.1016/j.bone.2023.117011
BibTeX
@article{Siverino2024,
author = {Siverino, Claudia and Tirkkonen-Rajasalo, Laura and Freitag, Linda and Günther, Christian and Thompson, Keith and Styger, Ursula and Zeiter, Stephan and Eglin, David and Stadelmann, Vincent A},
title = {Restoring implant fixation strength in osteoporotic bone with a hydrogel locally delivering zoledronic acid and bone morphogenetic protein 2. A longitudinal in vivo microCT study in rats},
journal = {Bone},
year = {2024},
doi = {10.1016/j.bone.2023.117011}
}
EUVIMED